Medicaid dominates coverage of Novo, Lilly weight-loss drugs
State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...
Microsoft Copilot's underperformance is the latest red flag for investments in AI
Microsoft's Copilot has yet to live up to the tech giant's massive expectations. It's the latest hiccup gen AI bets are ...
Weight-loss drug Wegovy launched in China
Novo Nordisk said Monday it has launched its popular obesity drug Wegovy in China, the world’s second-largest pharmaceuticals market where it estimates more than 180 million people live with obesity.